Danielle Lightsey, RPh
Danielle Lightsey is a pharmacist.
Is this your author page?
Make it work for you. Your KevinMD author page is one of the highest-ranking results for your name. An enhanced author page turns this page into a premium profile with your photo, biography, affiliations, publications, and links, publishes your accepted articles in 1 to 3 days, includes a listing in Experts by KevinMD, and comes with a guaranteed interview on The Podcast by KevinMD. See an example · See the enhanced author page → Cancel anytime.
Latest articles
Drugs and prescribing

A medication recall can answer an important question about a product while leaving the patient's next question unresolved: What should I do about my next dose? That gap matters. A headline may name a medicine without identifying the particular package…
A medication recall can answer an important question about a product while leaving the patient’s next question unresolved: What should I do about my next dose?
That gap matters. A headline may name a medicine without identifying the particular package in a person’s home. A notice may explain a manufacturing problem without explaining how an individual will obtain a replacement. Information about a defective product and advice about continuing treatment serve …
Read more…
After an FDA recall, patients need a plan for the next dose
Drugs and prescribing

For several years, glucagon-like peptide-1 (GLP-1) medications seemed to dominate conversations in community pharmacy. Patients called asking whether specific products were available, prescriptions were transferred between pharmacies, and pharmacy staff spent considerable time checking inventories and monitoring shortages. It was…
For several years, glucagon-like peptide-1 (GLP-1) medications seemed to dominate conversations in community pharmacy. Patients called asking whether specific products were available, prescriptions were transferred between pharmacies, and pharmacy staff spent considerable time checking inventories and monitoring shortages. It was not unusual for patients to call multiple times or travel significant distances in search of a medication that was difficult to obtain.
GLP-1 receptor agonists, including semaglutide (Ozempic and Wegovy) and …
Read more…
The GLP-1 shortage ended. The adherence problem did not.
Real physician voices, twice a week
Free, and one click to unsubscribe.